Amyloid beta deposits in brain of Alzheimer’s patient. What’s the News: A drug used to cure skin cancer is also a possible treatment for Alzheimer’s, according to a new study in Science . The drug not only reduced levels of amyloid beta —a protein whose elevated levels are a hallmark ... continue reading
WEDNESDAY, Sept. 28 (HealthDay News) — A new study shows that levels of amyloid beta, a byproduct of brain activity that is considered a marker for Alzheimer’s disease, normally rise during the day and decrease at night.
Follow this link:
... continue reading
Advancing age is a major risk factor for Alzheimer’s disease and is associated with build- up of the peptide amyloid beta in the brain. New research shows that removal of amyloid beta from the brain depends on vitamin D and also on an age-related alteration in the production of transporter ... continue reading
The emergence of multiple new brain imaging technologies and the combined application of these new approaches is helping to create new insights into aging and Alzheimer’s disease. One of the hallmarks of Alzheimer’s disease is the deposition of amyloid beta protein in clumps or “plaques” within the brain. These plaques ... continue reading
( University of California – San Diego ) New insights on what causes Alzheimer’s disease could arise from a recent discovery made by bioengineers from the University of California, San Diego. The finding concerns the infamous amyloid beta peptides (A?) — fragments of which form plaques thought to play a ... continue reading